Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Jan 15, 2024
Open Peer Review Period: Jan 17, 2024 - Mar 13, 2024
Date Accepted: May 20, 2025
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

How to Improve Pancreatic Cancer Network Care Using a Human-Centered Design Sprint

Hopstaken JS, Koeneman M, Hooijer R, van Rijssel CC, van Voorthuizen T, Oort FA, Blanken CF, de Groot M, van Laarhoven CJ, Stommel MW

How to Improve Pancreatic Cancer Network Care Using a Human-Centered Design Sprint

J Med Internet Res 2025;27:e55598

DOI: 10.2196/55598

PMID: 40911870

PMCID: 12413184

How to Improve Pancreatic Cancer Network Care Using A Human Centered Design Sprint

  • Jana S. Hopstaken; 
  • Mats Koeneman; 
  • Robin Hooijer; 
  • Concha C. van Rijssel; 
  • Theo van Voorthuizen; 
  • Frank A. Oort; 
  • Charlotte F.J.M. Blanken; 
  • Martijn de Groot; 
  • Cees J.H.M. van Laarhoven; 
  • Martijn W.J. Stommel

ABSTRACT

Background:

Pancreatic cancer is considered a complex cancer requiring specific expertise in diagnostic workup and multimodality treatment. Often multiple healthcare providers in different hospitals are involved during patient care. This fragmentation of care challenges healthcare providers in the network to deliver efficient, coherent and continuous network care.

Objective:

The aim of this study was to find means to improve network care for patients diagnosed with pancreatic cancer by applying a human centered design methodology.

Methods:

A Human Centered Design (HCD) Sprint was conducted in July 2020. The sprint comprised five days with different goals: Empathize, Define, Ideate, Prototype and Test. Experts and stakeholders were approached from the pancreatic cancer network to contribute. Patients and next of kin were interviewed about their experiences of network care prior to the Sprint. By using HCD a goal was defined, various prototypes were explored and one prototype was tested.

Results:

The HCD Sprint led to a shared goal which was to deliver pancreatic cancer network care in a (virtual) hospital in which there is ‘one narrative’. This means that the patient’s context and preferences are always clear and taken into account, care is characterized by a short time to diagnosis and treatment and patient data is easily available for patients and involved clinicians. The accompanying prototypes were 1) Network agreements 2) Patient Itinerary 3) Transmural Trajectory Guidance and 4) Data sharing. For the latter, we developed and pilot-tested a real-time data sharing dashboard CONNECT. The first pilot-test was promising and provided feedback for further development.

Conclusions:

The HCD sprint resulted in several useful prototypes based on which a real-time data sharing dashboard (CONNECT) was developed and pilot tested. The next steps include further development of the dashboard, implementation in our network and long-term evaluation studies. Clinical Trial: not applicable


 Citation

Please cite as:

Hopstaken JS, Koeneman M, Hooijer R, van Rijssel CC, van Voorthuizen T, Oort FA, Blanken CF, de Groot M, van Laarhoven CJ, Stommel MW

How to Improve Pancreatic Cancer Network Care Using a Human-Centered Design Sprint

J Med Internet Res 2025;27:e55598

DOI: 10.2196/55598

PMID: 40911870

PMCID: 12413184

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.